
N-Acetyl-DL-aspartic acid | CAS:2545-40-6
N-Acetyl-DL-aspartic acid
- 名称:N-乙酰-DL-天冬氨酸; N-乙酰-DL-天门冬氨酸 | N-Acetyl-DL-aspartic acid
- CAS号:2545-40-6
- 别名:
- 分子式:C6H9NO5
- 分子量:175.14
- EINESC号:219-827-5
产品描述
物理化学性质
没有数据 | 没有数据 |
---|
安全数据
没有数据 | 没有数据 |
---|
SDS
来源 | SDS样本 |
---|---|
Sigma-Aldrich | 浏览或下载 |
产品合成路线
名称 | CAS号 |
---|
更多
文章
同行评议文献
Chemical genetics reveals a complex functional ground state of neural stem cells.Phedias Diamandis et al.Nature chemical biology, 3(5), 268-273 (2007-04-10)
Long QT syndrome with nocturnal cardiac events caused by a KCNH2 missense mutation (G604S).Akinori Sato et al.Internal medicine (Tokyo, Japan), 51(14), 1857-1860 (2012-07-24)
A novel SCN9A mutation responsible for primary erythromelalgia and is resistant to the treatment of sodium channel blockers.Min-Tzu Wu et al.PloS one, 8(1), e55212-e55212 (2013-02-06)
Effect of mexiletine on sea anemone toxin-induced non-inactivating sodium channels of rat skeletal muscle: a model of sodium channel myotonia.J F Desaphy et al.Neuromuscular disorders : NMD, 9(3), 182-189 (1999-06-26)
Primary erythromelalgia in a 12-year-old boy: positive response to sodium channel blockers despite negative SCN9A mutations.A Jakob et al.Klinische Padiatrie, 224(5), 309-312 (2011-12-16)
Bisphenol A binds to the local anesthetic receptor site to block the human cardiac sodium channel.Andrias O O'Reilly et al.PloS one, 7(7), e41667-e41667 (2012-08-01)
Pharmacological therapies for muscular dystrophies.Hoda Abdel-Hamid et al.Current opinion in neurology, 25(5), 604-608 (2012-09-04)
Cardioprotective effects of sarcolemmal and mitochondrial K-ATP channel openers in an experimental model of autoimmune myocarditis. Role of the reduction in calcium overload during acute heart failure.Shinichi Niwano et al.International heart journal, 53(2), 139-145 (2012-06-13)
Synthesis and toxicopharmacological evaluation of m-hydroxymexiletine, the first metabolite of mexiletine more potent than the parent compound on voltage-gated sodium channels.Alessia Catalano et al.Journal of medicinal chemistry, 55(3), 1418-1422 (2011-12-24)
Drug-induced hypersensitivity syndrome complicated with concurrent fulminant type 1 diabetes mellitus and Hashimoto's thyroiditis.Yusuke Minegaki et al.International journal of dermatology, 52(3), 355-357 (2013-02-19)
An improved synthesis of m-hydroxymexiletine, a potent mexiletine metabolite.Alessia Catalano et al.Drug metabolism letters, 6(2), 124-128 (2012-08-02)
Drug-induced hypersensitivity syndrome complicated with concurrent fulminant type 1 diabetes mellitus and Hashimoto's thyroiditis.Yusuke Minegaki et al.International journal of dermatology, 52(3), 355-357 (2013-02-19)
Wide QRS Tachycardia in a young patient.Robert J Hariman et al.Archives of internal medicine, 172(7), 537-537 (2012-04-12)
Primary erythromelalgia in a 12-year-old boy: positive response to sodium channel blockers despite negative SCN9A mutations.A Jakob et al.Klinische Padiatrie, 224(5), 309-312 (2011-12-16)
A predictive ligand-based Bayesian model for human drug-induced liver injury.Sean Ekins et al.Drug metabolism and disposition: the biological fate of chemicals, 38(12), 2302-2308 (2010-09-17)
Stereospecific synthesis of m-Hydroxymexiletine enantiomers.Alessia Catalano et al.Drug metabolism letters, 6(3), 182-186 (2012-11-13)
Mexiletine for symptoms and signs of myotonia in nondystrophic myotonia: a randomized controlled trial.Jeffrey M Statland et al.JAMA, 308(13), 1357-1365 (2012-10-04)
Developing structure-activity relationships for the prediction of hepatotoxicity.Nigel Greene et al.Chemical research in toxicology, 23(7), 1215-1222 (2010-06-18)
Combined modifications of mexiletine pharmacophores for new lead blockers of Na(v)1.4 channels.Michela De Bellis et al.Biophysical journal, 104(2), 344-354 (2013-02-28)
Mexiletine is an effective antimyotonia treatment in myotonic dystrophy type 1.E L Logigian et al.Neurology, 74(18), 1441-1448 (2010-05-05)
Mexiletine Usage in a Chronic Pain Clinic: Indications, Tolerability, and Side Effects.Adam Romman et al.Pain physician, 21(5), E573-E579 (2018-10-05)
Mexiletine for treatment of myotonia: a trial triumph for rare disease networks.Eric P Hoffman et al.JAMA, 308(13), 1377-1378 (2012-10-04)
A sodium channel pore mutation causing Brugada syndrome.Arnold E Pfahnl et al.Heart rhythm, 4(1), 46-53 (2007-01-03)
Inhibition of late sodium current by mexiletine: a novel pharmotherapeutical approach in timothy syndrome.Yuanfeng Gao et al.Circulation. Arrhythmia and electrophysiology, 6(3), 614-622 (2013-04-13)
Asymmetric hydrolytic kinetic resolution with recyclable macrocyclic Co(III)-salen complexes: a practical strategy in the preparation of (R)-mexiletine and (S)-propranolol.Arghya Sadhukhan et al.Chemistry (Weinheim an der Bergstrasse, Germany), 18(17), 5256-5260 (2012-03-17)
Etodolac, a cyclooxygenase-2 inhibitor, attenuates paclitaxel-induced peripheral neuropathy in a mouse model of mechanical allodynia.Sunao Ito et al.The Journal of pharmacology and experimental therapeutics, 342(1), 53-60 (2012-03-31)
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.Jing Yuan et al.Nature chemical biology, 5(10), 765-771 (2009-09-08)
Detecting drug-induced prolongation of the QRS complex: new insights for cardiac safety assessment.C Cros et al.Toxicology and applied pharmacology, 265(2), 200-208 (2012-10-18)
Rufinamide attenuates mechanical allodynia in a model of neuropathic pain in the mouse and stabilizes voltage-gated sodium channel inactivated state.Marc R Suter et al.Anesthesiology, 118(1), 160-172 (2012-12-12)
Non-dystrophic myotonia: prospective study of objective and patient reported outcomes.Jaya R Trivedi et al.Brain : a journal of neurology, 136(Pt 7), 2189-2200 (2013-06-19)
Voltage-gated Na+ channel blockers reduce functional bladder capacity in the conscious spontaneously hypertensive rat.Angela K Clouse et al.Urology, 79(6), 1410-1410 (2012-04-14)
Oxidative stress in the in vivo DMBA rat model of breast cancer: suppression by a voltage-gated sodium channel inhibitor (RS100642).Kadir Batcioglu et al.Basic & clinical pharmacology & toxicology, 111(2), 137-141 (2012-03-21)
Inhibitory effects of class I and IV antiarrhythmic drugs on the Na+-activated K+ channel current in guinea pig ventricular cells.K Mori et al.Naunyn-Schmiedeberg's archives of pharmacology, 358(6), 641-648 (1999-01-08)
Atrial selectivity in Na+channel blockade by acute amiodarone.Tomoyuki Suzuki et al.Cardiovascular research, 98(1), 136-144 (2013-01-24)
Biophysical characterization of M1476I, a sodium channel founder mutation associated with cold-induced myotonia in French Canadians.Juan Zhao et al.The Journal of physiology, 590(11), 2629-2644 (2012-01-18)
Evaluation of in vitro models of stem cell-derived cardiomyocytes to screen for potential cardiotoxicity of chemicals.Miaoying Shi et al.Toxicology in vitro : an international journal published in association with BIBRA, 67, 104891-104891 (2020-05-25)
MexiletineMonk, Jon P and Brogden, Rex N Drugs, 40(3), 374-411 (1990)
Induced pluripotent stem cells used to reveal drug actions in a long QT syndrome family with complex genetics.Cecile Terrenoire et al.The Journal of general physiology, 141(1), 61-72 (2013-01-02)
Enantioselective drug-protein interaction between mexiletine and plasma protein.Lushan Yu et al.The Journal of pharmacy and pharmacology, 64(6), 792-801 (2012-05-11)
Erythromelagia: a rare and hard-to-treat condition: a 9-year-old boy responsive to intravenous lidocaine and oral mexilitene.Francisca Elgueta et al.Pain medicine (Malden, Mass.), 14(2), 311-312 (2013-02-02)
备注
Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).
名称 | CAS号 |
---|

相关产品
相关资讯
问
热门标签
询 单
请 填 写 相 关 信 息
- 请填写产品名称!
- CAS号
- 请正确填写公司名称!
- 请正确填写联系人!
- 请正确填写联系电话!
- 请正确填写联系邮箱!
- 请描述您的问题!